Tweet
http://clinicaltrials.gov/ct2/show/N...ns_ex=Y&rank=2
Oh how I wish I lived in Boston. The Massachusettes Eye and Ear Infirmary seems to do all the cutting edge research. The rest of us have to wait 5-10 years for the drugs to get through the trials and fda approvals!
Topical IL-1Ra for Treatment of Posterior Blepharitis
This study is currently recruiting participants.
Verified by Massachusetts Eye and Ear Infirmary, May 2008
Sponsored by: Massachusetts Eye and Ear Infirmary
Information provided by: Massachusetts Eye and Ear Infirmary
ClinicalTrials.gov Identifier: NCT00681109
Purpose
The purpose of this study is to determine the effectiveness and safety of Topical Interleukin-1-Receptor Antagonist in treatment of signs and symptoms of posterior blepharitis
Condition Intervention Phase
Posterior Blepharitis
Drug: IL-1Ra
Drug: Placebo
Phase I
Oh how I wish I lived in Boston. The Massachusettes Eye and Ear Infirmary seems to do all the cutting edge research. The rest of us have to wait 5-10 years for the drugs to get through the trials and fda approvals!
Topical IL-1Ra for Treatment of Posterior Blepharitis
This study is currently recruiting participants.
Verified by Massachusetts Eye and Ear Infirmary, May 2008
Sponsored by: Massachusetts Eye and Ear Infirmary
Information provided by: Massachusetts Eye and Ear Infirmary
ClinicalTrials.gov Identifier: NCT00681109
Purpose
The purpose of this study is to determine the effectiveness and safety of Topical Interleukin-1-Receptor Antagonist in treatment of signs and symptoms of posterior blepharitis
Condition Intervention Phase
Posterior Blepharitis
Drug: IL-1Ra
Drug: Placebo
Phase I